Sponsor:
Northwell Health
Code:
NCT05287841
Conditions
Nasal Obstruction
Septal Defect
Allergic Rhinitis
Nasal Polyps
Nasal Valve Collapse
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Batten batten graft
Septoplasty
Inferior Turbinate Reduction
Brief summary:
Conditions
Nasal Obstruction
Septal Defect
Allergic Rhinitis
Nasal Polyps
Nasal Valve Collapse
Study ID
NCT05287841
Start date
Apr 30, 2021
Status verified date
Sep, 2024
Completion date
Jun 15, 2025
Anticipated
Primary completion date
Dec 31, 2024
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
96 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Batten graft, plus septoplasty and inferior turbinate reduction
active comparator: Septoplasty and inferior turbinate reduction alone
Interventions
Batten batten graft
Septoplasty
Inferior Turbinate Reduction
Primary outcome measure
Central contacts
Locations
Lenox Hill Hospital/Staten Island University Hospital
Recruiting
New York, New York, United States, 10075
Contacts
Principal Investigator:
David Hiltzik, MD
Staten Island University Hospital
Recruiting
Staten Island, New York, United States, 10305
Contacts
Principal Investigator:
David Hiltzik, MD
Sponsor
Northwell Health
Last update posted
Sep 20, 2024
Last verified
Sep, 2024
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Northwell Health on 2024-09-20.